SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-19-000014
Filing Date
2019-04-01
Accepted
2019-04-01 08:58:51
Documents
4
Period of Report
2019-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 26437
2 EXHIBIT 99.1 a190401conferenceabstrac.htm EX-99.1 958
3 a190401conferenceabstrac001.jpg GRAPHIC 200498
4 a190401conferenceabstrac002.jpg GRAPHIC 42979
  Complete submission text file 0001583648-19-000014.txt   364198
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 19718955
SIC: 8731 Services-Commercial Physical & Biological Research